BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24069156)

  • 41. Cervical cancer screening in the United States and the Netherlands: a tale of two countries.
    Habbema D; De Kok IM; Brown ML
    Milbank Q; 2012 Mar; 90(1):5-37. PubMed ID: 22428690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
    Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
    PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of Pap smear and its influencing factors among women with disabilities in Taiwan.
    Huang KH; Tsai WC; Kung PT
    Res Dev Disabil; 2012; 33(2):307-14. PubMed ID: 22100350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model.
    Lott BE; Trejo MJ; Baum C; McClelland DJ; Adsul P; Madhivanan P; Carvajal S; Ernst K; Ehiri J
    BMC Public Health; 2020 May; 20(1):654. PubMed ID: 32393218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical cancer screening among Lebanese women.
    Bou-Orm IR; Sakr RE; Adib SM
    Rev Epidemiol Sante Publique; 2018 Feb; 66(1):1-6. PubMed ID: 29249573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Pap smear screening results between Akha hill tribe and urban women in Chiang Rai province, Thailand.
    Kritpetcharat O; Wutichouy W; Sirijaichingkul S; Kritpetcharat P
    Asian Pac J Cancer Prev; 2012; 13(11):5501-4. PubMed ID: 23317207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution.
    Gharoro EP; Ikeanyi EN
    Int J Gynecol Cancer; 2006; 16(3):1063-8. PubMed ID: 16803486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moroccan Women's Attitudes Regarding Pap Smear Test and Adherence to Cervical Cancer Screening.
    Yacouti A; Baddou R; El Mettat K; Guennouni M; El Got A; Aquil A; Ennaji MM; Boumba ALM; Benider A; Mouallif M
    J Cancer Educ; 2023 Oct; 38(5):1649-1655. PubMed ID: 37418146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knowledge, attitudes, and practice of the Pap smear test in female college students attending a global university in the United States.
    Tolosko JA; Beauchesne M; Rancatore E
    J Am Assoc Nurse Pract; 2023 May; 35(5):322-329. PubMed ID: 36862575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pap smear accuracy for the diagnosis of cervical precancerous lesions.
    Nkwabong E; Laure Bessi Badjan I; Sando Z
    Trop Doct; 2019 Jan; 49(1):34-39. PubMed ID: 30222058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda.
    Mutyaba T; Mmiro FA; Weiderpass E
    BMC Med Educ; 2006 Mar; 6():13. PubMed ID: 16509979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perceptions of Midwives on Pap Smear Tests during Pregnancy.
    Abdul AE; Mudau TS; Chabedi MA
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):3039-3043. PubMed ID: 33112565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya.
    Gichangi P; Estambale B; Bwayo J; Rogo K; Ojwang S; Opiyo A; Temmerman M
    Int J Gynecol Cancer; 2003; 13(6):827-33. PubMed ID: 14675320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knowledge and practices on breast and cervical cancer screening methods among female health care workers: a Sri Lankan experience.
    Nilaweera RI; Perera S; Paranagama N; Anushyanthan AS
    Asian Pac J Cancer Prev; 2012; 13(4):1193-6. PubMed ID: 22799304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attitudes and knowledge of Georgian physicians regarding cervical cancer prevention, 2010.
    Bednarczyk RA; Butsashvili M; Kamkamidze G; Kajaia M; McNutt LA
    Int J Gynaecol Obstet; 2013 Jun; 121(3):224-8. PubMed ID: 23497751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The frequency of Pap smear screening in the United States.
    Sirovich BE; Welch HG
    J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervical cancer screening: who is not screened and why?
    Harlan LC; Bernstein AB; Kessler LG
    Am J Public Health; 1991 Jul; 81(7):885-90. PubMed ID: 2053665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.